Capstone Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.72M | Buy |
17,400
+13,300
| +324% | +$6.38M | 0.02% | 368 |
|
|
2026
Q1 | $2.02M | Sell |
4,100
-2,700
| -40% | -$1.47M | ﹤0.01% | 642 |
|
|
2025
Q4 | $3.94M | Sell |
6,800
-2,900
| -30% | -$1.64M | 0.01% | 421 |
|
|
2025
Q3 | $4.7M | Buy |
9,700
+1,100
| +13% | +$512K | 0.01% | 489 |
|
|
2025
Q2 | $3.49M | Sell |
8,600
-6,500
| -43% | -$2.72M | 0.01% | 478 |
|
|
2025
Q1 | $7.51M | Sell |
15,100
-15,100
| -50% | -$8.18M | 0.02% | 363 |
|
|
2024
Q4 | $15.7M | Buy |
30,200
+8,600
| +40% | +$4.73M | 0.04% | 265 |
|
|
2024
Q3 | $13.4M | Buy |
21,600
+1,700
| +9% | +$1.01M | 0.04% | 249 |
|
|
2024
Q2 | $11M | Buy |
19,900
+3,300
| +20% | +$1.89M | 0.03% | 292 |
|
|
2024
Q1 | $9.65M | Sell |
16,600
-15,500
| -48% | -$8.7M | 0.03% | 283 |
|
|
2023
Q4 | $17M | Buy |
32,100
+12,900
| +67% | +$6.24M | 0.05% | 241 |
|
|
2023
Q3 | $9.72M | Buy |
19,200
+1,000
| +5% | +$533K | 0.04% | 281 |
|
|
2023
Q2 | $9.5M | Buy |
18,200
+700
| +4% | +$378K | 0.05% | 263 |
|
|
2023
Q1 | $10.1M | Buy |
17,500
+7,800
| +80% | +$4.4M | 0.05% | 240 |
|
|
2022
Q4 | $5.34M | Buy |
9,700
+2,800
| +41% | +$1.48M | 0.04% | 364 |
|
|
2022
Q3 | $3.5M | Sell |
6,900
-2,200
| -24% | -$1.23M | 0.02% | 519 |
|
|
2022
Q2 | $4.94M | Sell |
9,100
-39,200
| -81% | -$21.6M | 0.02% | 416 |
|
|
2022
Q1 | $28.5M | Sell |
48,300
-36,000
| -43% | -$20.7M | 0.08% | 191 |
|
|
2021
Q4 | $56.2M | Buy |
84,300
+9,100
| +12% | +$5.68M | 0.09% | 180 |
|
|
2021
Q3 | $43M | Buy |
75,200
+19,200
| +34% | +$10.5M | 0.09% | 207 |
|
|
2021
Q2 | $28.3M | Buy |
56,000
+2,700
| +5% | +$1.27M | 0.06% | 272 |
|
|
2021
Q1 | $24.3M | Sell |
53,300
-3,300
| -6% | -$1.58M | 0.07% | 249 |
|
|
2020
Q4 | $26.4M | Buy |
56,600
+15,700
| +38% | +$7.36M | 0.09% | 187 |
|
|
2020
Q3 | $18.1M | Buy |
40,900
+8,000
| +24% | +$3.31M | 0.09% | 189 |
|
|
2020
Q2 | $11.9M | Buy |
32,900
+13,200
| +67% | +$4.42M | 0.08% | 218 |
|
|
2020
Q1 | $5.59M | Sell |
19,700
-33,200
| -63% | -$10.5M | 0.09% | 250 |
|
|
2019
Q4 | $17.2M | Buy |
52,900
+7,300
| +16% | +$2.21M | 0.09% | 230 |
|
|
2019
Q3 | $13.3M | Buy |
45,600
+15,000
| +49% | +$4.3M | 0.09% | 228 |
|
|
2019
Q2 | $8.99M | Buy |
30,600
+10,300
| +51% | +$2.84M | 0.07% | 317 |
|
|
2019
Q1 | $5.56M | Buy |
20,300
+16,200
| +395% | +$4.03M | 0.05% | 327 |
|
|
2018
Q4 | $918K | Buy |
4,100
+1,400
| +52% | +$328K | 0.01% | 644 |
|
|
2018
Q3 | $659K | Buy |
2,700
+900
| +50% | +$207K | 0.01% | 721 |
|
|
2018
Q2 | $373K | Buy |
+1,800
| New | +$382K | 0.01% | 513 |
|
Other funds holding TMO
Capstone Investment Advisors's TMO Position: Q2 2026 in Review
Capstone Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 81% in Q2 2026, selling an estimated $867K and leaving 428 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.
Capstone Investment Advisors first reported a position in TMO in Q2 2014 and has held it in 33 quarters since. The position peaked at $15M in Q1 2021. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Capstone Investment Advisors held 428 shares of Thermo Fisher Scientific worth $215K as of Q2 2026.
- Capstone Investment Advisors sold 1,807 Thermo Fisher Scientific shares in Q2 2026, an estimated $867K.
- Thermo Fisher Scientific made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1589 holding.
- Capstone Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 33 quarters since.
- Capstone Investment Advisors's Thermo Fisher Scientific position peaked at $15M in Q1 2021.
- 2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.